Moreover, the results of the K-M survival analysis revealed that patients with high immune infiltration of Tem or Th2 cells experienced shorter OS, while the level of CD8 + T cell infiltration was not related to the OS of patients with pancreatic cancer (Fig. S8). The gene discussed is CD8A; the disease is familial pancreatic carcinoma.